Cas:28947-77-5 N,N-dihexadecylhexadecan-1-amine manufacturer & supplier

Chemical Name:N,N-dihexadecylhexadecan-1-amine

CAS.NO:28947-77-5

Synonyms:1-Hexadecanamine,N,N-dihexadecyl;tricetylamine;N,N-dihexadecyl-1-hexadecanamine;Tri(hexadecyl)amin;Tricetylamin;trihexadecyl-amine

Molecular Formula:C₄₈H₉₉N

Molecular Weight:690.30600

HS Code:2921199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:700.5ºC at 760mmHg

Density:0.833g/cm3

Index of Refraction:1.463

PSA:3.24000

Exact Mass:689.77800

LogP:17.73230

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-Hexadecanamine,N,N-dihexadecyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trihexadecyl-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tricetylamine Use and application,trihexadecyl-amine technical grade,usp/ep/jp grade.

Related News: First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. N,N-dihexadecylhexadecan-1-amine manufacturer Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. N,N-dihexadecylhexadecan-1-amine supplier In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. N,N-dihexadecylhexadecan-1-amine vendor Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. N,N-dihexadecylhexadecan-1-amine factory In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements.